NCT04303455

Brief Summary

Study design Observational, single centre, prospective cohort study Planned sample size 100 participants Inclusion criteria The study will evaluate a cohort of participants meeting the following inclusion criteria:

  1. 1.admission to the Intensive Care Unit (ICU) after elective and emergency cardiac surgery using cardiopulmonary bypass
  2. 2.age 18 years and above
  3. 3.arterial, central venous and pulmonary arterial catheters have been inserted as part of routine care Study procedures In addition to routine clinical postoperative data and blood collection, serum renin levels will be analysed on admission, 6 and 24 hours after admission to ICU Study duration 6 months

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 11, 2020

Completed
13 days until next milestone

Study Start

First participant enrolled

March 24, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2021

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2021

Completed
Last Updated

March 24, 2021

Status Verified

March 1, 2021

Enrollment Period

11 months

First QC Date

March 8, 2020

Last Update Submit

March 22, 2021

Conditions

Keywords

Biomarkers of shockBiomarkers of adverse outcomes in shocked patientsBiomarkers of adverse outcomes in cardiothoracic patients

Outcome Measures

Primary Outcomes (1)

  • Patterns of changes in serum renin concentrations are associated with composite morbidity at 30 days in participants who have undergone cardiac surgery.

    30 days

Secondary Outcomes (3)

  • Patterns of changes in serum renin concentrations correlate with current markers of resuscitation in participants who have undergone cardiac surgery ( C.I, SvO2, MAP, urine output, serum lactate, based deficit, venoarterial CO2 gradients)

    24 hours

  • Serum renin concentrations correlate with Pmsa in postoperative cardiac surgical patients

    24 hours

  • Patterns of changes in serum renin concentrations are associated with AKI or the need for CRRT in participants who have undergone cardiac surgery

    30 days

Study Arms (1)

Study group

The study will evaluate a cohort of participants meeting the following inclusion criteria: 1. Admission to ICU after elective and emergency cardiac surgery following cardiopulmonary bypass 2. Age 18 years and above 3. Arterial, central venous and pulmonary arterial catheters have been inserted as part of routine care Data collection, serum renin among routine blood collection on admission, 6 and 24 hours after admission to ICU

Diagnostic Test: blood sampling

Interventions

blood samplingDIAGNOSTIC_TEST

sampling serum renin

Study group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Admission to ICU after elective and emergency cardiac surgery following cardiopulmonary bypass

You may qualify if:

  • Admission to ICU after elective and emergency cardiac surgery following cardiopulmonary bypass
  • Age 18 years and above
  • Arterial, central venous catheters and pulmonary arterial catheters are inserted preoperatively

You may not qualify if:

  • Age under 18 years
  • Known pregnancy
  • Arterial, central venous catheters and pulmonary arterial catheters that are not indicated as part of routine care
  • End stage renal disease requiring renal replacement therapy
  • Participants with known Child Pugh A cirrhosis or greater
  • Treatment with any steroids
  • Participant is not expected to live beyond the day after the day of admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr Wajid Khan

Sydney, New South Wales, 2170, Australia

Location

Related Publications (4)

  • Nguyen M, Denimal D, Dargent A, Guinot PG, Duvillard L, Quenot JP, Bouhemad B. Plasma Renin Concentration is Associated With Hemodynamic Deficiency and Adverse Renal Outcome in Septic Shock. Shock. 2019 Oct;52(4):e22-e30. doi: 10.1097/SHK.0000000000001285.

    PMID: 30407370BACKGROUND
  • Myles PS. Meaningful outcome measures in cardiac surgery. J Extra Corpor Technol. 2014 Mar;46(1):23-7.

    PMID: 24779115BACKGROUND
  • Hall A, Busse LW, Ostermann M. Angiotensin in Critical Care. Crit Care. 2018 Mar 20;22(1):69. doi: 10.1186/s13054-018-1995-z.

  • Khanna AK. Tissue Perfusion and Prognosis in the Critically Ill-Is Renin the New Lactate? Crit Care Med. 2019 Feb;47(2):288-290. doi: 10.1097/CCM.0000000000003582. No abstract available.

MeSH Terms

Conditions

Shock

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 8, 2020

First Posted

March 11, 2020

Study Start

March 24, 2020

Primary Completion

February 15, 2021

Study Completion

March 12, 2021

Last Updated

March 24, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Results of the study will be shared

Locations